Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

71.65p
   
  • Change Today:
    -1.35p
  • 52 Week High: 171.20
  • 52 Week Low: 67.00
  • Currency: UK Pounds
  • Shares Issued: 961.88m
  • Volume: 209,202
  • Market Cap: £689.19m

Tuesday broker round-up

By Caoimhe Toman

Date: Tuesday 13 Jul 2021

LONDON (ShareCast) - (Sharecast News) - Dr Martens: Goldman Sachs upgrades to buy with a target price of 535p.

Entain: Berenberg reiterates buy with a target price of 2,080p.

Rentokil: Berenberg reiterates sell with a target price of 415p.

Trustpilot Group: Berenberg reiterates buy with a target price of 430p.

Dechra: JP Morgan reiterates overweight with a target price of 5,200p.

Marks & Spencer: JP Morgan reiterates neutral with a target price of 173p.

Just Eat Takeaway: Morgan Stanley reiterates overweight with a target price of 11,100p.

boohoo: RBC Capital Markets upgrades to outperform with a target price of 410p.

Rio Tinto: RBC Capital Markets reiterates sector perform with a target price of 5,900p.

Centamin: Liberum reiterates sell with a target price of 82p.

Kier Group: Liberum reiterates buy with a target price of 150p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 71.65p
Change Today -1.35p
% Change -1.85 %
52 Week High 171.20
52 Week Low 67.00
Volume 209,202
Shares Issued 961.88m
Market Cap £689.19m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.16% above the market average60.16% above the market average60.16% above the market average60.16% above the market average60.16% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Price Trend
83.49% below the market average83.49% below the market average83.49% below the market average83.49% below the market average83.49% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Income
66.42% above the market average66.42% above the market average66.42% above the market average66.42% above the market average66.42% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
6.67% below the market average6.67% below the market average6.67% below the market average6.67% below the market average6.67% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 04-Jan-24 08-Jun-23
Paid 02-Feb-24 18-Jul-23
Amount 1.56p 4.28p

Trades for 25-Apr-2024

Time Volume / Share Price
08:47 294 @ 71.65p
08:47 59 @ 71.65p
08:47 667 @ 71.60p
08:47 2,265 @ 71.60p
08:47 576 @ 71.55p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson
CFO Jon Mortimore

Top of Page